Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemoline in Stimulant Dependence
NCT00000340Phase 2Withdrawn
- Sponsor
- National Institute on Drug Abuse
- Start
- Jun 1996
- Modality
- Small Molecules
01
Overview
Phase 2 trial of pemoline in cocaine dependence, methamphetamine use disorder (MUD) and attention deficit hyperactivity disorder (ADHD), sponsored by National Institute on Drug Abuse. Primary endpoints: Retention, Depression and 5 more. Planned start Jun 1996; status: withdrawn.
02
Drugs
pemoline
03
Conditions
cocaine dependencemethamphetamine use disorder (MUD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00000340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000340.